Table 2. Overall complications.
| Total Group(n = 566) | No urological complication(n = 448) | With urological Complication(n = 118) | p-value* | |
| Overall surgical intervention (%) | 132 (23.3%) | 85 (19.0%) | 47 (39.8%) | <0.001 |
| ATN (%) | 240 (42.4%) | 187 (41.7%) | 53 (44.9%) | 0.535 |
| Tacrolimus toxicity (>15 µg/l) (%) | 63 (11.1%) | 47 (10.5%) | 16 (13.6%) | 0.346 |
| Surgical site infection (%) | 50 (8.8%) | 34 (7.6%) | 16 (13.6%) | 0.042 |
| Urinary tract infection (%) | 130 (23.0%) | 84 (18.8%) | 46 (39.0%) | <0.001 |
| Lymphocele (%) | 17 (3.0%) | 3 (0.7%) | 14 (11.9%) | <0.001 |
| Rejection treatment (%) | 71 (12.5%) | 54 (12.0%) | 17 (14.4%) | 0.492 |
| Primary non-function (%) | 51 (9.0%) | 46 (10.3%) | 5 (4.2%) | 0.042 |
*p-value is provided between the group without urological complications and the group with urological complications.
PCN: Percutaneous Nephrostomy; ATN: Acute Tubulus Necrosis.